Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia — Stella

Home/Chemotherapy Induced Nausea and Vomiting/

View on ClinicalTrials.gov

Recruiting

Back to Chemotherapy Induced Nausea and Vomiting trials

Trial locations(1 site)

China

Anhui Children's Hospital, Hefei, Anhui

Key details

Sponsor

Anhui Provincial Children's Hospital

Enrollment target

~500 participants

Started

November 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

2 Years – 17 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.